We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Wyatt Demonstrates Strength in Macromolecular Characterization Solutions
News   Dec 26, 2005

Wyatt will be exhibiting its comprehensive range of products on booth #1944, PittCon 2006.

READ MORE

NIST Releases a Major Upgrade of Mass Spectra Library
News   Dec 23, 2005

The library is an encyclopedic database of "fingerprints" used to identify chemical compounds.

READ MORE

Exelixis and Wyeth Sign License Agreement
News   Dec 23, 2005

The agreement is related to compounds targeting the receptor implicated in metabolic and liver disorders.

READ MORE

DNAPrint Completes Acquistion of Ellipsis Biotherapeutics
News   Dec 23, 2005

Ellipsis Biotherapeutics acquisition strengthens DNAPrint’ position in the diagnostic and clinical patient testing market.

READ MORE

Acumen and deCODE Chemistry Initiate Drug Discovery Research
News   Dec 23, 2005

The target of this programme is to identify potential therapeutic treatments for Alzheimer’s Disease.

READ MORE

MDL Isentris Platform Selected by LEO Pharma
News   Dec 22, 2005

Discovery informatics architecture enhances R&D productivity by integrating informatics and workflow.

READ MORE

LifeSpan Announces Agreement with Pfizer
News   Dec 22, 2005

Pfizer will gain access to all the features of the LifeSpan’ DrugTarget Database™.

READ MORE

LabTrader Wins 2005 Emerging Family Business of the Year Award
News   Dec 22, 2005

LabTrader has been recognized by the San Diego Business Journal and the USD Family Business Forum.

READ MORE

Hybrigenics Provides Its Technology Tools to Genethon
News   Dec 22, 2005

The program will allow a better understanding of the muscle and the development of therapeutic leads.

READ MORE

Avalon Announces Expiration of the Sanofi-Aventis Agreement
News   Dec 22, 2005

The agreement established a collaboration to utilize molecular cytogenetics to identify and validate oncology targets.

READ MORE